2008China Practical MedicineRequires access

Assess effects of edaravone combined with batroxobin in treatment of progressive cerebral infarction pa-tients

HU Yong-tao, Cheng Li

Open publisher page 0 citations

Abstract

Objective To observe the efficacy of edaravone combined with batroxobin for progressive cerebral infarction.Methods The study was performed on progressive cerebral infarction patients(80cases),enrolled within 48 hour of onset.They were randomly divided into treatment group(40patients)and control group(40patients).The treatment group was allocated edaravone and batroxobin,and control group was allocated batroxobin.And then to observe the improvement of neurological function and the change of the fibrinogen in the blood.Results After three weeks,the apparent rate of the treatment group was 85%,higher than that of the control group 72.5%(P0.05).After two treatments the fibrinogen cut down dramatically(both P0.01).Conclusion Edaravone combined with batroxobin is an effective and safe therapy method for treating progressive cerebral infarction.

About this research paper

What this paper is about

Objective To observe the efficacy of edaravone combined with batroxobin for progressive cerebral infarction.Methods The study was performed on progressive cerebral infarction patients(80cases),enrolled within 48 hour of onset.They were randomly divided into treatment group(40patients)and control group(40patients).The treatment group was allocated edaravone and batroxobin,and control group was allocated batroxobin.And then to observe the improvement of neurological function and the change of the fibrinogen in the blood.Results After three weeks,the apparent rate of the treatment group was 85%,higher than that of the control group 72.5%(P0.05).After two treatments the fibrinogen cut down dramatically(both P0.01).Conclusion Edaravone combined with batroxobin is an effective and safe therapy method for treating progressive cerebral infarction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the efficacy of edaravone combined with batroxobin for progressive cerebral infarction.Methods The study was performed on progressive cerebral infarction patients(80cases),enrolled within 48 hour of onset.They were randomly divided into treatment group(40patients)and control group(40patients).The treatment group was allocated edaravone and batroxobin,and control group was allocated batroxobin.And then to observe the improvement of neurological function and the change of the fibrinogen in the blood.Results After three weeks,the apparent rate of the treatment group was 85%,higher than that of the control group 72.5%(P0.05).After two treatments the fibrinogen cut down dramatically(both P0.01).Conclusion Edaravone combined with batroxobin is an effective and safe therapy method for treating progressive cerebral infarction.

Key concepts: Batroxobin, Edaravone, Medicine, Cerebral infarction, Fibrinogen, Anesthesia, Surgery, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Assess effects of edaravone combined with batroxobin in treatment of progressive cerebral infarction pa-tients — Research Paper | ScholarLens